# Subarachnoid Hemorrhage Diagnostic Testing

Evaluate suspected subarachnoid hemorrhage with immediate noncontrast CT, using headache timing and CT interpretation quality to determine whether lumbar puncture, CT angiography, or vascular imaging is still required.

**Clinical question:** How should clinicians sequence CT, lumbar puncture, CTA, and angiography when evaluating suspected subarachnoid hemorrhage?

Updated: 2026-09-15T21:17:39.052290+00:00

## What matters in practice
- In patients with acute severe headache, noncontrast head CT performed within 6 hours of onset has pooled sensitivity of 98.7% when interpreted by a radiologist experienced in brain imaging; sensitivity falls to 90% or less after 6 hours. [5][7]
- The Ottawa SAH Rule is highly sensitive but poorly specific (pooled sensitivity 99.5%, specificity 24%); use it to avoid missed high-risk presentations, not to establish SAH. [5][7]
- After a negative CT when residual concern for SAH remains, lumbar puncture with spectrophotometric CSF analysis is a high-sensitivity pathway; CTA is an alternative in selected patients but introduces vascular and incidental-aneurysm findings that require interpretation. [5][6][20]
- A positive noncontrast CT should trigger urgent vascular imaging to identify the bleeding source and transfer or management in a center with neurocritical care and aneurysm-treatment expertise. [13][21]

## Who needs urgent testing for subarachnoid hemorrhage

Treat thunderclap headache as a time-dependent imaging problem rather than a symptom diagnosis.

Obtain immediate noncontrast head CT for a patient with sudden severe headache when the presentation is concerning for nontraumatic SAH. Delayed diagnosis is associated with worse outcomes, and thunderclap headache also warrants consideration of intracranial hemorrhage and other vascular disorders. [6]

The Ottawa SAH Rule can identify patients at very low risk among the rule's intended acute-headache population, but a positive rule result should be understood as an imaging trigger rather than evidence of hemorrhage. In pooled validation data, sensitivity was 99.5% (95% CI, 90.8%-100%) but specificity only 24% (95% CI, 15.5%-34.4%), so broad application substantially increases testing. [5][7]

Do not use a normal neurologic examination alone to end the evaluation. The strongest early-CT evidence applies specifically to neurologically intact patients with a high-quality CT obtained promptly after headache onset and interpreted by an experienced reader. [20]
- Document the best estimate of ictus time before interpreting a negative CT as a rule-out study; the clinically important cutoff is 6 hours from headache onset. [5][7]
- If onset time is uncertain, manage the negative CT as a study performed beyond the validated early-CT interval and pursue additional testing when suspicion persists. [5][7]
- A diagnostic pathway for suspected SAH may also identify other clinically important causes of acute headache, including intracerebral hemorrhage, tumor, and meningitis. [7]

*Initial diagnostic choices in suspected nontraumatic SAH. [5][6][7][20]*

| Clinical setting | First test | Interpretation that changes the next step |
| --- | --- | --- |
| Sudden severe headache with concern for SAH | Noncontrast head CT immediately | Subarachnoid blood establishes hemorrhage and should prompt vascular source evaluation. [6][13] |
| Negative CT within 6 hours, neurologically intact, expert brain-image interpretation | Assess CT quality, timing, and residual pretest concern | Pooled CT sensitivity is 98.7%; selected patients may forgo further SAH testing after shared clinical assessment. [5][7][20] |
| Negative CT performed more than 6 hours after ictus or uncertain timing | Lumbar puncture or selected CTA pathway | CT sensitivity beyond 6 hours was 90% or less in available studies; do not treat the scan as equivalently exclusionary. [5][7] |
| Positive CT or proven SAH | CTA and, when needed, catheter angiography | Identify a vascular cause and expedite definitive aneurysm-directed evaluation. [6][13] |

## When a negative head CT is sufficient

The safety of a CT-only strategy depends on timing, scanner performance, reader expertise, and patient selection.

For suspected SAH, obtain noncontrast CT before lumbar puncture because CT detects acute hemorrhage and rapidly identifies alternative structural emergencies. In a systematic review of diagnostic studies, CT performed within 6 hours had pooled sensitivity of 98.7% (95% CI, 96.5%-100%) and specificity of 100% (95% CI, 99.7%-100%). [5][7]

The early-CT rule-out approach requires more than a clock time. The cited clinical framework specifies a third-generation or higher CT scanner, imaging within 6 hours of onset, a neurologically intact patient, and a scan read as normal by a neuroradiologist; under those conditions, further testing was considered unnecessary. [20]

After 6 hours, negative CT is materially less reassuring. The pooled review found sensitivity of 90% or less in the two studies evaluating later imaging; proceed to CSF testing or a selected CTA-based approach when the clinical concern remains meaningful. [5][7]

CT technique and interpretation remain operationally important. In the prospective early-CT cohort, scanners were third-generation multislice systems, and sites used 5-7.5 mm brain cuts with 2.5-5 mm posterior-fossa cuts after 2002; do not automatically extrapolate early-CT performance to nondiagnostic studies, poor-quality scans, or settings without routine brain-imaging expertise. [8]
- Before accepting a negative CT-only result, verify: known onset within 6 hours, noncontrast acquisition, technically adequate study, and interpretation by a radiologist who routinely interprets brain imaging. [5][20]
- A patient with persistent high clinical concern despite an early negative CT deserves individualized additional testing; the pooled early-CT sensitivity is high but not mathematically absolute. [5][7]
- MRI with fluid-attenuated inversion recovery and susceptibility-weighted sequences can be sensitive for SAH, particularly days after ictus, but is not the first-line acute test in the standard thunderclap-headache pathway. [20]

*How CT timing changes post-CT testing. [5][7][20]*

| CT result and timing | Residual concern | Recommended diagnostic direction |
| --- | --- | --- |
| Positive noncontrast CT at any time | SAH established | Obtain vascular imaging to define the bleeding source and arrange aneurysm-treatment evaluation. [13][21] |
| Negative CT within 6 hours under validated conditions | Low after high-quality expert interpretation | CT-only exclusion may be reasonable in a neurologically intact patient after assessing pretest probability and imaging quality. [20] |
| Negative CT after 6 hours | Persistently clinically important | Perform LP with CSF analysis or consider CTA in selected cases. [5][6][7] |
| Negative CT with uncertain onset or inadequate interpretation | Cannot apply early-CT evidence reliably | Use the delayed or indeterminate pathway: LP or selected CTA, based on clinical context and test tradeoffs. [5][6][20] |

## How to use lumbar puncture after a negative CT

Lumbar puncture remains the principal confirmatory test when CT does not adequately exclude SAH.

After a negative noncontrast CT obtained beyond 6 hours, perform lumbar puncture when the residual probability of SAH justifies an invasive test. In pooled diagnostic data, LP with spectrophotometric CSF analysis after negative CT had sensitivity of 100% and specificity of 95% (95% CI, 86.0%-98.5%). [5][7]

Request CSF xanthochromia assessment using spectrophotometry when available and clinically applicable. Spectrophotometric analysis is the method evaluated in the pooled high-sensitivity LP studies; visual xanthochromia and red-cell counts have different limitations and should not be treated as interchangeable assays. [5][7][24]

Interpret CSF red blood cells cautiously because traumatic taps are common and may be difficult to distinguish from SAH. A review cites a final-tube RBC threshold of 2,000 × 10^6/L with sensitivity 93% and specificity 93% for aneurysmal SAH, whereas lower final-tube thresholds trade sensitivity for specificity; therefore, a low or falling RBC count alone should not override the clinical and xanthochromia context. [24]

LP can also redirect the diagnosis toward meningitis or another disorder when CT is negative. This broader diagnostic yield is a practical advantage over a vascular-only strategy, particularly when fever, meningismus, immunocompromise, or altered mental status broadens the differential. [7]
- Use LP primarily when CT timing is greater than 6 hours, onset is uncertain, CT quality is limited, or pretest concern remains substantial after negative CT. [5][7]
- Order and document the laboratory's actual xanthochromia method; spectrophotometry has stronger diagnostic-accuracy support than visual inspection. [5][7][8]
- Interpret an RBC-positive CSF sample in conjunction with xanthochromia, CT timing, examination, and vascular imaging rather than labeling every bloody specimen as SAH. [20][24]

*CSF interpretation issues after negative CT. [5][7][20][24]*

| CSF finding or issue | Interpretive limitation | Actionable response |
| --- | --- | --- |
| Spectrophotometric xanthochromia analysis | Method-specific result; availability varies by laboratory | Use as the preferred CSF analytic approach when LP is pursued for CT-negative suspected SAH. [5][7] |
| Blood in CSF | Traumatic tap may mimic SAH | Do not diagnose or exclude SAH using red cells alone; integrate xanthochromia and clinical context. [20][24] |
| Final-tube RBC <2,000 × 10^6/L | Reported threshold had 93% sensitivity and 93% specificity, not perfect exclusion | Do not use as a stand-alone rule-out when concern remains or xanthochromia is present. [24] |
| Negative CT plus LP pathway | LP may yield false-positive results and lower pathway specificity | Balance the residual SAH risk against invasive testing and the consequences of ambiguous CSF findings. [7] |

## When CTA or catheter angiography should follow CT

CTA answers a different question from LP: it seeks a vascular lesion rather than directly detecting CSF blood products.

Obtain CTA after CT-confirmed SAH to identify an aneurysm or another vascular cause and to guide urgent cerebrovascular treatment planning. AHA/ASA guidance emphasizes management in centers with dedicated neurocritical care, multidisciplinary expertise, and experience treating aneurysms, which should influence early transfer decisions when these services are unavailable. [13]

For CT-negative thunderclap headache, CTA can be an alternative to LP in selected cases, especially when LP is difficult or unacceptable, but it should be chosen deliberately. CTA can identify vascular causes of thunderclap headache, whereas MRI/MRA may reveal alternative diagnoses such as cerebral venous thrombosis or reversible cerebral vasoconstriction syndrome and may also produce incidental findings with uncertain management implications. [6][20]

A CTA-detected aneurysm does not by itself prove that the aneurysm caused the headache or that occult SAH occurred. Interpret a vascular lesion with the noncontrast CT, CSF findings when obtained, headache phenotype, and neuroradiologic review; incidental intracranial aneurysms can create downstream procedural decisions. [4][20]

Proceed to digital subtraction angiography when noninvasive vascular imaging does not resolve the source in a patient with proven SAH or when neurovascular specialists require higher-resolution lesion characterization for treatment planning. Catheter angiography carries procedure-related risks including vessel dissection or perforation, embolic stroke, access-site bleeding, renal failure, and death, so reserve it for a result that will change management. [1]
- CT-positive SAH: obtain vascular imaging urgently and involve neurosurgery, neurointerventional specialists, and neurocritical care. [13][21]
- CT-negative, LP not feasible or not desired: CTA is a selective alternative, with counseling about detection of incidental aneurysms and the possibility that a negative CTA does not evaluate all nonaneurysmal headache causes. [6][20]
- Proven SAH with unrevealing or discordant noninvasive imaging: discuss catheter angiography promptly with the neurovascular team. [13][1]

*Selecting vascular imaging after suspected or confirmed SAH. [1][6][13][20]*

| Clinical question | Preferred test direction | Important tradeoff |
| --- | --- | --- |
| Is there acute intracranial blood? | Noncontrast head CT | High early diagnostic performance depends on timing and expert interpretation. [5][7][20] |
| Is there an aneurysm or other vascular cause after CT-positive SAH? | CTA followed by specialist-directed angiographic evaluation | Defining anatomy enables treatment planning but may require invasive imaging. [13][1] |
| Can vascular imaging substitute for LP after negative CT? | CTA in selected cases | Identifies vascular causes but may detect incidental aneurysms and is not the same biologic test as CSF analysis. [6][20] |
| Is a vascular lesion unresolved or treatment planning requires detailed anatomy? | Digital subtraction angiography | Higher procedural risk than noninvasive imaging, including ischemic and access complications. [1] |

## What confirmed subarachnoid hemorrhage changes immediately

Once hemorrhage is identified, diagnostic testing shifts from exclusion to source definition and complication surveillance.

A confirmed SAH should prompt urgent source evaluation because rebleeding before aneurysm repair is a major preventable complication. A meta-analysis summarized in a clinical review found rebleeding in 7%-26% of patients, with a mean of 13%; risk was associated with proximity to the initial hemorrhage, higher blood pressure, worse neurologic grade, intraventricular or intracerebral hemorrhage, and larger aneurysm. [20]

Transfer or admit to a center with neurocritical care and an experienced aneurysm-treatment team when feasible. Care in centers with dedicated neurocritical care units, higher case volume, physician expertise in aneurysm treatment, expert nursing, and multidisciplinary teams is associated with lower mortality and greater likelihood of good functional outcome. [13]

In a patient with later neurologic deterioration after aneurysmal SAH, do not attribute the deficit automatically to vasospasm. Device-trial eligibility criteria for symptomatic vasospasm specifically excluded symptoms attributable to hydrocephalus, metabolic causes, or infection, illustrating the need to reassess these competing causes before escalating vasospasm-directed interventions. [1]
- Document CT hemorrhage pattern, intraventricular extension, and intraparenchymal hematoma because these features influence source evaluation and rebleeding risk assessment. [20]
- Use multidisciplinary neurovascular review to select aneurysm treatment strategy rather than choosing clipping or endovascular therapy from a single imaging characteristic. [3][13]
- For new deficits during hospitalization, repeat focused neurologic assessment and evaluate alternative causes such as hydrocephalus, infection, and metabolic derangement alongside delayed cerebral ischemia. [1]

*Diagnostic priorities after SAH confirmation. [1][13][20][21]*

| Time point | Diagnostic priority | Result that changes action |
| --- | --- | --- |
| Immediately after CT confirmation | CTA or specialist-directed vascular imaging | Aneurysm or vascular lesion identification triggers urgent definitive-treatment planning. [13][21] |
| Before aneurysm is secured | Assess features linked to rebleeding risk | Early interval from ictus, higher blood pressure, worse grade, intraventricular/intracerebral blood, and larger aneurysm increase concern for rebleeding. [20] |
| New neurologic decline after aSAH | Reassess for hydrocephalus, metabolic causes, infection, and delayed cerebral ischemia | Alternative cause identified should be treated before labeling deterioration as vasospasm alone. [1] |

## References
1. [PDF] ESALIO - NeVa VS - accessdata.fda.gov — www.accessdata.fda.gov — https://www.accessdata.fda.gov/cdrh_docs/pdf21/H210004C.pdf
2. [PDF] NeuroFlo - accessdata.fda.gov — www.accessdata.fda.gov — https://www.accessdata.fda.gov/cdrh_docs/pdf3/H030005c.pdf
3. [PDF] 1 Free State Reporting, Inc. 1378 Cape St. Claire Road Annapolis ... — www.fda.gov — https://www.fda.gov/media/112132/download
4. [PDF] summary of safety and effectiveness data (ssed) - accessdata.fda.gov — www.accessdata.fda.gov — https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170032B.pdf
5. systematic review of diagnostic accuracy studies — emj.bmj.com — https://emj.bmj.com/content/emermed/39/11/818.full.pdf
6. Assessment and investigation of thunderclap headache - The BMJ — www.bmj.com — https://www.bmj.com/content/389/bmj-2024-083247.full.pdf
7. Management of patients presenting to the emergency department with sudden onset severe headache: systematic review of diagnostic accuracy studies | Emergency Medicine Journal — emj.bmj.com — https://emj.bmj.com/content/39/11/818
8. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study — www.bmj.com — https://www.bmj.com/content/343/bmj.d4277
9. A Randomized Clinical - JAMA Network — jamanetwork.com — https://jamanetwork.com/journals/jamaneurol/articlepdf/10.1001/jamaneurol.2023.1792
10. Predictors and Impact of Aneurysm Rebleeding After Subarachnoid ... — jamanetwork.com — https://jamanetwork.com/journals/jamaneurology/fullarticle/787971
11. Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients ... — jamanetwork.com — https://jamanetwork.com/journals/jamaneurology/fullarticle/2806583
12. Comment on the 2023 Guidelines for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage — www.ahajournals.org — https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.123.043541
13. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association | Stroke — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STR.0000000000000436?s=09
14. Diagnosis and management of subarachnoid haemorrhage - Nature — www.nature.com — https://www.nature.com/articles/s41467-024-46015-2
15. External multicenter validation of the eSAH score for predicting ... — www.nature.com — https://www.nature.com/articles/s41598-025-34326-3_reference.pdf
16. External multicenter validation of the eSAH score for predicting outcomes after subarachnoid hemorrhage | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-025-34326-3
17. Management of hypertensive crisis: British and Irish ... - Nature — www.nature.com — https://www.nature.com/articles/s41371-022-00776-9
18. Sensitivity of Early Brain Computed Tomography to Exclude ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/strokeaha.115.011386
19. Effectiveness of Diagnostic Strategies in Suspected Delayed ... — stroke.ahajournals.org — http://stroke.ahajournals.org/cgi/content/full/46/1/77
20. Treatment of Spontaneous Subarachnoid Hemorrhage — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STROKEAHA.119.025997
21. Subarachnoid Hemorrhage — journals.lww.com — https://journals.lww.com/continuum/abstract/2018/12000/subarachnoid_hemorrhage.6.aspx
22. Twelve controversial questions in aneurysmal subarachnoid hemorrhage — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0210569123002644
23. Evaluating the strength and quality of evidence in American heart association/American stroke association's guidelines for aneurysmal subarachnoid hemorrhage and spontaneous intracerebral hemorrhage - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1052305724003549
24. Controversies in the Diagnosis of Subarachnoid Hemorrhage - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0736467915011579

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.